EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Terminal heart failure care for women: better or more of the same?

Vithoosharan Sivanathan iD, Natasha Smallwood iD, Dominica Zentner iD

Internal Medicine Journal · 2025

DOI: 10.1111/imj.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Vithoosharan Sivanathan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Heart Failure, Terminal Care, Palliative Care. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Women with chronic heart failure (CHF) experience an increased symptom burden, activity impairment and frailty. Although receiving palliative care services has been shown to improve the quality of life of people with CHF, few patients access this in a timely manner.

Aim

Explore whether there were differences in either referral to specialist palliative care or provision of elements of palliative care to women and men with CHF during their terminal admission in Australia.

Methods

This is a retrospective review of medical records for all admissions resulting in death from chronic heart failure (July 2011 to December 2019).

Results

The cohort ( n = 439) was elderly (median age 83.7 years, IQR = 77.6–88.7) and composed of 199 (45.1%) women. There was no association between sex and receiving an inpatient referral to specialist palliative care ( P = 0.80). Women were less likely to receive life‐sustaining interventions (intubation, inotropes, resuscitation, ICU stay) (odds ratio [OR] = 1.71, 1.04–2.83; P = 0.04) compared to men. Women were more likely to receive terminal symptom‐related management (opioids or benzodiazepines) (OR = 3.19, 1.54–6.63; P = 0.01) or a palliative approach (OR = 1.68, 1.14–2.45; P < 0.01). Women were less likely to present to the emergency department (OR = 0.50, 0.31–0.79; P = 0.04) or be referred to an outpatient chronic disease programme (OR = 0.58, 0.34–0.98; P = 0.04) in the 12 months prior to death compared to men.

Conclusion

Given accepted differences in the timeliness of cardiac care for women, the apparent finding of better end‐of‐life care for women is intriguing and merits further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureTerminal CarePalliative CareHumansFemaleRetrospective StudiesAgedMaleAged, 80 and overAustraliaSex FactorsReferral and ConsultationQuality of Life

Stichwörter der Autor:innen

heart failurepalliative caresex differenceterminal admission

Autor:innen und Institutionen

  • Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Department of Respiratory Medicine, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Department of Allergy, Immunology and Respiratory Medicine, School of Translational Medicine, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
  • Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

ORCID-Profile: Vithoosharan Sivanathan, Natasha Smallwood, Dominica Zentner

Zitieren

APA

Sivanathan, V., Smallwood, N., & Zentner, D. (2025). Terminal heart failure care for women: better or more of the same?. Internal Medicine Journal. https://doi.org/10.1111/imj.70077

Vancouver

Sivanathan V, Smallwood N, Zentner D. Terminal heart failure care for women: better or more of the same?. Internal Medicine Journal. 2025. doi:10.1111/imj.70077

BibTeX
@article{Sivanathan2025,
  author = {Sivanathan, Vithoosharan and Smallwood, Natasha and Zentner, Dominica},
  title = {Terminal heart failure care for women: better or more of the same?},
  journal = {Internal Medicine Journal},
  year = {2025},
  doi = {10.1111/imj.70077}
}
Kostenlos starten →